Related Experiment Video
Updated: Jun 19, 2026

Isolation Protocol of Mouse Monocyte-derived Dendritic Cells and Their Subsequent In Vitro Activation with Tumor Immune Complexes
Published on: May 31, 2018
Pharmacological inhibitors of the mevalonate pathway activate pro-IL-1 processing and IL-1 release by human monocytes
Benoit Massonnet1, Sylvain Normand, Reinhard Moschitz
1Laboratoire Inflammation, Tissus Epithéliaux et Cytokines, EA 4331, Université de Poitiers, Poitiers, France.
Objective:
The effects of statins (3-hydroxy-3-methylglutaryl coenzyme A reductase-HMGR-inhibitors) on the inflammatory response remain unclear. HMGR is implicated in the mevalonate pathway, directly upstream of cholesterol biosynthesis. We studied the impairment by this pathway of cytokine production by peripheral blood mononuclear cells (PBMCs) and THP-1 cells. The aim was to identify a specific cytokine "signature" of cells under simvastatin treatment in order to link pharmacological inhibition of the mevalonate pathway and inflammation.
Methods:
Normal human PBMCs and THP-1 cells were cultured with inhibitors of HMGR (simvastatin), geranylgeranyltransferase (GGTI-298), farnesyltransferase (FTI-277), and/or caspase-1 (Z-VAD(Ome)-FMK). Following culture, cytokine production, caspase-1 activity, IL-1beta mRNA and Rac-1 activity were determined.
Results:
Pharmacological inhibition of the mevalonate pathway specifically enhanced the release of IL-1alpha, IL-1beta and IL-18 and inhibited IL-1ra production by LPS-activated PBMCs and THP-1 cells. Simvastatin did not modify pro-IL-1beta expression, but enhanced caspase-1 activity, the enzyme responsible for IL-1beta and IL-18 maturation. GGTI-298 also enhanced IL-1-family cytokine production, showing that geranylgeranylation is involved in caspase-1 activation. Additionally, simvastatin enhanced Rac-1 activity.
Conclusion:
Pharmacological inhibition of the mevalonate pathway by statins highlighted the specific induction of the proinflammatory cytokines of the IL-1 family whose maturation is either directly (i.e. IL-1beta and IL-18), or indirectly (i.e. IL-1alpha) dependant on caspase-1.
Insights
Statins, by inhibiting the mevalonate pathway, specifically increase pro-inflammatory cytokines like IL-1alpha, IL-1beta, and IL-18. This occurs via enhanced caspase-1 activity, linking statin use to inflammation modulation.
Area of Science:
- Biochemistry
- Immunology
- Pharmacology
Background:
- The impact of statins (3-hydroxy-3-methylglutaryl coenzyme A reductase-HMGR-inhibitors) on inflammatory responses is not fully understood.
- HMGR plays a key role in the mevalonate pathway, upstream of cholesterol biosynthesis.
- Investigating the mevalonate pathway's influence on cytokine production is crucial for understanding statin's effects on inflammation.
Purpose of the Study:
- To determine the specific cytokine signature induced by simvastatin treatment in peripheral blood mononuclear cells (PBMCs) and THP-1 cells.
- To elucidate the link between pharmacological inhibition of the mevalonate pathway and cellular inflammatory responses.
- To identify how statin-mediated HMGR inhibition affects cytokine production.
Main Methods:
- Culturing human PBMCs and THP-1 cells with HMGR inhibitors (simvastatin), geranylgeranyltransferase inhibitor (GGTI-298), farnesyltransferase inhibitor (FTI-277), and caspase-1 inhibitor (Z-VAD(Ome)-FMK).
- Assessing cytokine production, caspase-1 activity, IL-1beta mRNA levels, and Rac-1 activity post-culture.
- Utilizing lipopolysaccharide (LPS) to activate PBMCs and THP-1 cells for cytokine release studies.
Main Results:
- Simvastatin treatment specifically enhanced the release of IL-1alpha, IL-1beta, and IL-18, while inhibiting IL-1ra production in LPS-activated cells.
- Simvastatin increased caspase-1 activity, crucial for IL-1beta and IL-18 maturation, without altering pro-IL-1beta expression.
- Geranylgeranylation inhibition by GGTI-298 also boosted IL-1-family cytokine production, indicating its role in caspase-1 activation. Simvastatin also increased Rac-1 activity.
Conclusions:
- Pharmacological inhibition of the mevalonate pathway using statins distinctly induces pro-inflammatory cytokines of the IL-1 family.
- The maturation of IL-1beta and IL-18 is directly promoted by caspase-1 activation, while IL-1alpha maturation is indirectly affected.
- These findings highlight a specific inflammatory cytokine signature associated with statin therapy, mediated by caspase-1-dependent mechanisms.
Related Concept Videos
Inhibitors of Viral Protein Synthesis
IP3/DAG Signaling Pathway
Amplifying Signals via Enzymatic Cascade
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
GPCRs Regulate Adenylyl Cylase Activity
Two...
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

